Bontril

   
Google
 
Web NewDrugInformation.com

Bontril


Drug - Bontril
The trade name of the product as shown on the labeling.

Dosage - CAPSULE, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Phendimetrazine Tartrate
Multiple ingredients are in alphabetical order.

Strength - 105MG
The potency of the active ingredient(s), Phendimetrazine Tartrate. May repeat for multiple part products.

Applicant - MALLINCKRODT
The firm name holding legal responsibility for Bontril. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088021
The FDA assigned number to Bontril. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Bontril. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - BC
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 21, 1982
The date Bontril was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Bontril. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Bontril is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mallinckrodt Chemical Inc
The full name of the firm holding legal responsibility for the new application of Bontril.

Bontril